💊

Qtern

saxagliptin;dapagliflozin

Diabete mellito di tipo 2;Diabete mellito;Malattie nutrizionali e metaboliche;Malattie metaboliche;Disturbi del metabolismo del glucosio

✅ Autorizzato

✅

Nessun allarme attivo

Questo medicinale non presenta carenze in corso, lettere di sicurezza o richiami.

A cosa serve

Qtern, fixed dose combination of saxagliptin and dapagliflozin, is indicated in adults aged 18 years and older with type 2 diabetes mellitus: to improve glycaemic control when metformin and/or sulphonylurea (SU) and one of the monocomponents of Qtern do not provide adequate glycaemic control, when already being treated with the free combination of dapagliflozin and saxagliptin. (See sections 4.2, 4.4, 4.5 and 5.1 for available data on combinations studied.)

⚠️ Sicurezza del paziente

Pagina ufficiale EMA

https://www.ema.europa.eu/en/medicines/human/EPAR/qtern